Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Topline Data from a Randomized, Double Blind, Placebo Controlled Phase 2 Study of ATH434 in Multiple System Atrophy

Sustained Chorea Improvements with Long-term, Once-daily Valbenazine in Adults with Huntington’s Disease

Clinical Characteristics Associated With High Baseline Glial Fibrillary Acidic Protein (GFAP) and Neurofilament Light Chain (NfL) Levels in Patients With Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD) From the